Apathy and agitation: Challenges and future directions

American Journal of Geriatric Psychiatry

Volumn 15, Issue 5, 2007, Pages 361-364

  Lyketsos, Constantine ^a  

^a John Hopkins Bayview ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGITATION; ALZHEIMER DISEASE; APATHY; APATHY EVALUATION SCALE; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DISEASE COURSE; EDITORIAL; GERONTOPSYCHIATRY; MEDICAL PRACTICE; NEUROPSYCHIATRIC INVENTORY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOMETRY; SCORING SYSTEM; AFFECT; AGED; DIFFERENTIAL DIAGNOSIS; HUMAN; PSYCHOLOGICAL ASPECT; RESTLESSNESS;

AFFECT; AGED; ALZHEIMER DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; PSYCHOMOTOR AGITATION;

EID: 34447127540     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e31803d15c1     Document Type: Editorial

References (18)

1. Onyike CU, Sheppard JME, Tschanz JT, et al: Epidemiology of apathy in older adults: the Cache County Study. Am J Ger Psychiatry 2007; 15:365-375
2. Lueken U, Seidl U, Völker L, Schweiger E, Schröder J: Development of a short version of the Apathy Evaluation Scale (AES) specifically adapted for demented nursing home residents. Am J Ger Psychiatry 2007; 15:376-385
3. Lavretsky HM, Ballmaier M, Pham D, Toga A, Kumar A: Neuroanatomical characteristics of geriatric apathy and depression: an MRI study. Am J Ger Psychiatry 2007; 15:386-394
4. Lyketsos CG: Lessons from Neuropsychiatry. J Neuropsychiatry Clin Neurosci 2006; 18:445-449
5. Lyketsos CG, Rosenblatt AR, Rabins PV: Forgotten Frontal lobe Syndrome. Or, Executive Dysfunction Syndrome. Psychosomatics 2004; 45:247-255
6. Marin R, Biedrzycki R, Firinciogullari S: Reliability and validity of the AES. Psychiatry Research 1991; 38:143-162
7. Politis AM, Vozzella S, Mayer LS, Onyike CU, Baker AS, Lyketsos CG: A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care. Int J Ger Psychiatry 2004; 19:1087-1094
8. Cohen-Mansfield J: Temporal patterns of agitation in dementia. Am J Ger Psychiatry 2007; 15:395-405
9. Sharp SI, Ballard CG, Chen CPL-H, Francis PT: Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer's Disease. Am J Ger Psychiatry 2007; 15:435-437
10. Lai MK, Tsang SW, Francis PT, et al: Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res 2003; 974:82-87
11. Garcia-Alloza M, Gil-Bea FJ, Diez-Ariza M, et al: Cholinergicserotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. Neuropsychologia 2005; 43:442-449
12. Schneider LS, Dagerman K, Insel PS: Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006;14:191-210
13. Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294:1934-1943
14. Wang PS, Schneeweiss S, Avorn J, et al: Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353:2335-2341
15. Pollock BG, Mulsant BH, Rosen J, et al: Comparison of citalopram, perphenazine and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry 2002; 159:460-465
16. Peskind ER, Tsuang DW, Bonner LT, et al: Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study. Alzheimer Dis Assoc Disord 2005; 19:23-28
17. Lyketsos CG: The importance of neuropsychiatric symptoms (aka, BPSD) as outcomes. Int Psychogeriatrics, in press
18. Lyketsos CG, Rabins PV, Breitner JCS: An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease. Int J Ger Psychiatry 2001; 16:1037-1042